LHLABCORP HOLDINGS INC.
- Market cap
- $26.68B
- as of 2026-10-23
- Latest close
- $328.95
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Diagnostics & Research
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-16
Showing the latest 500 of 691 transactions.
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Caveney Brian JEVP, Pres of BLS, CMO & CSO | Sep 1 | Sep 3 | A · derivative | 3,000 | $0.00 | $0 | 7,170 | No | Form 4 |
| Vaughn Bryan TEVP and President, Diagnostics | Sep 1 | Sep 3 | A · derivative | 1,500 | $0.00 | $0 | 5,204 | No | Form 4 |
| Meltzer Jonathan CEVP, COO | Sep 1 | Sep 3 | A · derivative | 900 | $0.00 | $0 | 3,594 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Sep 1 | Sep 3 | A · derivative | 750 | $0.00 | $0 | 2,940 | No | Form 4 |
| Anderson Kerrii B | Aug 17 | Aug 18 | S | 3,000 | $318.02 | Sale −$954,060 | 6,563 | Yes | Form 4 |
| Schechter Adam HPresident & CEO | Aug 11 | Aug 12 | S | 4,669 | $320.37 | Sale −$1,495,808 | 102,565 | Yes | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Aug 4 | Aug 6 | S | 924 | $306.74 | Sale −$283,428 | 6,955.5 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Aug 3 | Aug 5 | S | 82 | $309.22 | Sale −$25,356 | 1,770.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Aug 3 | Aug 5 | M | 1,338 | $209.25 | $279,977 | 3,108.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Aug 3 | Aug 5 | S | 1,338 | $309.23 | Sale −$413,750 | 1,770.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Aug 3 | Aug 5 | M · derivative | 1,338 | $209.25 | $279,977 | not reported | No | Form 4 |
| Vaughn Bryan TEVP and President, Diagnostics | Jul 2 | Jul 6 | S | 234 | $286.19 | Sale −$66,968 | 6,745.57 | Yes | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Jul 2 | Jul 6 | S | 92 | $286.19 | Sale −$26,329 | 3,904.46 | Yes | Form 4 |
| Vaughn Bryan TEVP and President, Diagnostics | Jul 1 | Jul 6 | M | 327 | not reported | not reported | 7,072.57 | Yes | Form 4 |
| Vaughn Bryan TEVP and President, Diagnostics | Jul 1 | Jul 6 | F | 93 | $283.88 | $26,401 | 6,979.57 | Yes | Form 4 |
| Vaughn Bryan TEVP and President, Diagnostics | Jul 1 | Jul 6 | M · derivative | 327 | $0.00 | $0 | 3,704 | Yes | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Jul 1 | Jul 6 | M | 256 | not reported | not reported | 4,069.46 | Yes | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Jul 1 | Jul 6 | F | 73 | $283.88 | $20,723 | 3,996.46 | Yes | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Jul 1 | Jul 6 | M · derivative | 256 | $0.00 | $0 | 2,008 | Yes | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Jun 8 | Jun 10 | S | 762 | $263.89 | Sale −$201,084 | 3,813.46 | Yes | Form 4 |
| Schechter Adam HPresident & CEO | May 11 | May 13 | S | 5,903 | $254.50 | Sale −$1,502,314 | 107,234 | Yes | Form 4 |
| Meltzer Jonathan CEVP, Operations | Mar 27 | Mar 30 | S | 839 | $267.05 | Sale −$224,055 | 3,620.33 | Yes | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Mar 27 | Mar 30 | S | 1,633 | $267.05 | Sale −$436,093 | 1,852.22 | Yes | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Mar 26 | Mar 30 | A | 1,184 | $0.00 | $0 | 5,332 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Mar 26 | Mar 30 | F | 481 | $268.38 | $129,091 | 4,851 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Mar 26 | Mar 30 | A | 1,584 | $0.00 | $0 | 5,026.46 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Mar 26 | Mar 30 | F | 451 | $268.38 | $121,039 | 4,575.46 | No | Form 4 |
| Meltzer Jonathan CEVP, Operations | Mar 26 | Mar 30 | A | 2,388 | $0.00 | $0 | 5,170.33 | Yes | Form 4 |
| Meltzer Jonathan CEVP, Operations | Mar 26 | Mar 30 | F | 711 | $268.38 | $190,818 | 4,459.33 | Yes | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Mar 26 | Mar 30 | A | 1,340 | $0.00 | $0 | 5,446.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Mar 26 | Mar 30 | F | 382 | $268.38 | $102,521 | 5,064.25 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Mar 26 | Mar 30 | A | 3,994 | $0.00 | $0 | 9,715.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Mar 26 | Mar 30 | F | 1,836 | $268.38 | $492,746 | 7,879.5 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Mar 26 | Mar 30 | A | 6,382 | $0.00 | $0 | 8,960.95 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Mar 26 | Mar 30 | F | 2,722 | $268.38 | $730,530 | 6,238.95 | No | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Mar 26 | Mar 30 | A | 1,584 | $0.00 | $0 | 7,196.57 | No | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Mar 26 | Mar 30 | F | 451 | $268.38 | $121,039 | 6,745.57 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Mar 26 | Mar 30 | A | 2,388 | $0.00 | $0 | 4,240.22 | Yes | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Mar 26 | Mar 30 | F | 755 | $268.38 | $202,627 | 3,485.22 | Yes | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Mar 26 | Mar 30 | A | 9,304 | $0.00 | $0 | 39,410.92 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Mar 26 | Mar 30 | F | 4,042 | $268.38 | $1,084,792 | 35,368.92 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Mar 26 | Mar 30 | A | 1,986 | $0.00 | $0 | 37,354.92 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Mar 26 | Mar 30 | F | 863 | $268.38 | $231,612 | 36,491.92 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Mar 26 | Mar 30 | A | 9,304 | $0.00 | $0 | 15,777.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Mar 26 | Mar 30 | F | 4,600 | $268.38 | $1,234,548 | 11,177.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Mar 26 | Mar 30 | A | 2,968 | $0.00 | $0 | 14,145.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Mar 26 | Mar 30 | F | 1,468 | $268.38 | $393,982 | 12,677.14 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Mar 26 | Mar 30 | A | 6,604 | $0.00 | $0 | 8,064 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Mar 26 | Mar 30 | F | 2,879 | $268.38 | $772,666 | 5,185 | No | Form 4 |
| Schechter Adam HPresident & CEO | Mar 26 | Mar 30 | A | 58,470 | $0.00 | $0 | 139,243 | No | Form 4 |
| Schechter Adam HPresident & CEO | Mar 26 | Mar 30 | F | 26,106 | $268.38 | $7,006,328 | 113,137 | No | Form 4 |
| Schechter Adam HPresident & CEO | Mar 3 | Mar 5 | S | 8,705 | $279.96 | Sale −$2,437,052 | 80,773 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Feb 27 | Mar 3 | S | 547.54 | $284.91 | Sale −$156,000 | 2,578.95 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 24 | Feb 26 | S | 1,500 | $286.31 | Sale −$429,465 | 30,106.92 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 19 | Feb 23 | S | 666 | $277.94 | Sale −$185,108 | 1,852.22 | Yes | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 12 | Feb 13 | S | 87 | $290.42 | Sale −$25,267 | 2,782.33 | Yes | Form 4 |
| Anderson Kerrii B | Feb 11 | Feb 13 | M | 897 | not reported | not reported | 9,563 | No | Form 4 |
| Anderson Kerrii B | Feb 11 | Feb 13 | M · derivative | 897 | $0.00 | $0 | 773 | No | Form 4 |
| Davis Jeffrey A. | Feb 11 | Feb 13 | M | 897 | not reported | not reported | 5,460 | No | Form 4 |
| Davis Jeffrey A. | Feb 11 | Feb 13 | M · derivative | 897 | $0.00 | $0 | 773 | No | Form 4 |
| Kliphouse Kirsten Marie | Feb 11 | Feb 13 | M | 897 | not reported | not reported | 3,160 | No | Form 4 |
| Kliphouse Kirsten Marie | Feb 11 | Feb 13 | M · derivative | 897 | $0.00 | $0 | 773 | No | Form 4 |
| Kong Garheng | Feb 11 | Feb 13 | M | 897 | not reported | not reported | 13,739 | No | Form 4 |
| Kong Garheng | Feb 11 | Feb 13 | M · derivative | 897 | $0.00 | $0 | 773 | No | Form 4 |
| Neupert Peter M | Feb 11 | Feb 13 | M | 897 | not reported | not reported | 13,784 | No | Form 4 |
| Neupert Peter M | Feb 11 | Feb 13 | M · derivative | 897 | $0.00 | $0 | 773 | No | Form 4 |
| Parham Richelle P | Feb 11 | Feb 13 | M | 897 | not reported | not reported | 3,366 | No | Form 4 |
| Parham Richelle P | Feb 11 | Feb 13 | M · derivative | 897 | $0.00 | $0 | 773 | No | Form 4 |
| Wengel Kathryn E | Feb 11 | Feb 13 | M | 897 | not reported | not reported | 4,133 | No | Form 4 |
| Wengel Kathryn E | Feb 11 | Feb 13 | M · derivative | 897 | $0.00 | $0 | 773 | No | Form 4 |
| Rothman Paul | Feb 11 | Feb 13 | M | 897 | not reported | not reported | 2,571 | No | Form 4 |
| Rothman Paul | Feb 11 | Feb 13 | M · derivative | 897 | $0.00 | $0 | 773 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 11 | Feb 13 | M | 403 | not reported | not reported | 4,286 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 11 | Feb 13 | F | 138 | $289.89 | $40,005 | 4,148 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 11 | Feb 13 | M · derivative | 403 | $0.00 | $0 | 2,827 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 11 | Feb 13 | M | 740 | not reported | not reported | 31,817.92 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 11 | Feb 13 | F | 211 | $289.89 | $61,167 | 31,606.92 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 11 | Feb 13 | M · derivative | 740 | $0.00 | $0 | 4,170 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 11 | Feb 13 | M | 356 | not reported | not reported | 1,569 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 11 | Feb 13 | F | 109 | $289.89 | $31,598 | 1,460 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 11 | Feb 13 | M · derivative | 356 | $0.00 | $0 | 2,401 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Feb 11 | Feb 13 | M | 216 | not reported | not reported | 3,504.46 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Feb 11 | Feb 13 | F | 62 | $289.89 | $17,973 | 3,442.46 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Feb 11 | Feb 13 | M · derivative | 216 | $0.00 | $0 | 2,264 | No | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 11 | Feb 13 | M | 243 | not reported | not reported | 2,939.33 | Yes | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 11 | Feb 13 | F | 70 | $289.89 | $20,292 | 2,869.33 | Yes | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 11 | Feb 13 | M · derivative | 243 | $0.00 | $0 | 2,694 | Yes | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 11 | Feb 13 | M | 230 | not reported | not reported | 4,174.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 11 | Feb 13 | F | 68 | $289.89 | $19,713 | 4,106.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 11 | Feb 13 | M · derivative | 230 | $0.00 | $0 | 2,190 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 11 | Feb 13 | S | 5,273 | $284.38 | Sale −$1,499,536 | 87,343 | Yes | Form 4 |
| Schechter Adam HPresident & CEO | Feb 11 | Feb 13 | M | 3,656 | not reported | not reported | 90,999 | Yes | Form 4 |
| Schechter Adam HPresident & CEO | Feb 11 | Feb 13 | F | 1,521 | $289.89 | $440,923 | 89,478 | Yes | Form 4 |
| Schechter Adam HPresident & CEO | Feb 11 | Feb 13 | M · derivative | 3,656 | $0.00 | $0 | 22,214 | Yes | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 11 | Feb 13 | M | 806 | not reported | not reported | 6,732.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 11 | Feb 13 | F | 259 | $289.89 | $75,082 | 6,473.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 11 | Feb 13 | M · derivative | 806 | $0.00 | $0 | 2,358 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Feb 11 | Feb 13 | M | 376 | not reported | not reported | 3,225.49 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Feb 11 | Feb 13 | F | 99 | $289.89 | $28,699 | 3,126.49 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Feb 11 | Feb 13 | M · derivative | 376 | $0.00 | $0 | 1,141 | No | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Feb 11 | Feb 13 | M | 323 | not reported | not reported | 5,705.57 | No | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Feb 11 | Feb 13 | F | 93 | $289.89 | $26,960 | 5,612.57 | No | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Feb 11 | Feb 13 | M · derivative | 323 | $0.00 | $0 | 4,031 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 11 | Feb 13 | M | 860 | not reported | not reported | 2,062.24 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 11 | Feb 13 | F | 245 | $289.89 | $71,023 | 1,817.24 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 11 | Feb 13 | M · derivative | 860 | $0.00 | $0 | 4,964 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11 | Feb 13 | M | 536 | not reported | not reported | 2,564.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11 | Feb 13 | F | 160 | $289.89 | $46,382 | 2,404.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11 | Feb 13 | M | 160 | not reported | not reported | 2,564.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11 | Feb 13 | F | 46 | $289.89 | $13,335 | 2,518.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11 | Feb 13 | M · derivative | 536 | $0.00 | $0 | 2,128 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11 | Feb 13 | M · derivative | 160 | $0.00 | $0 | 1,968 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 11 | Feb 13 | M | 230 | not reported | not reported | 5,804.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 11 | Feb 13 | F | 83 | $289.89 | $24,061 | 5,721.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 11 | Feb 13 | M · derivative | 230 | $0.00 | $0 | 1,304 | No | Form 4 |
| Anderson Kerrii B | Feb 10 | Feb 12 | A · derivative | 773 | $0.00 | $0 | 1,670 | No | Form 4 |
| Bulto Carulla Victor | Feb 10 | Feb 12 | A · derivative | 773 | $0.00 | $0 | 909 | No | Form 4 |
| Davis Jeffrey A. | Feb 10 | Feb 12 | A · derivative | 773 | $0.00 | $0 | 1,670 | No | Form 4 |
| Kliphouse Kirsten Marie | Feb 10 | Feb 12 | A · derivative | 773 | $0.00 | $0 | 1,670 | No | Form 4 |
| Neupert Peter M | Feb 10 | Feb 12 | A · derivative | 773 | $0.00 | $0 | 1,670 | No | Form 4 |
| Parham Richelle P | Feb 10 | Feb 12 | A · derivative | 773 | $0.00 | $0 | 1,670 | No | Form 4 |
| Wengel Kathryn E | Feb 10 | Feb 12 | A · derivative | 773 | $0.00 | $0 | 1,670 | No | Form 4 |
| Sampson John H | Feb 10 | Feb 12 | A · derivative | 773 | $0.00 | $0 | 773 | No | Form 4 |
| Rothman Paul | Feb 10 | Feb 12 | A · derivative | 733 | $0.00 | $0 | 1,670 | No | Form 4 |
| Kong Garheng | Feb 10 | Feb 12 | A · derivative | 773 | $0.00 | $0 | 1,670 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 10 | Feb 12 | A · derivative | 6,100 | $284.50 | $1,735,450 | 6,100 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 10 | Feb 12 | A · derivative | 2,020 | $0.00 | $0 | 4,910 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 10 | Feb 12 | A · derivative | 3,300 | $284.50 | $938,850 | 3,300 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 10 | Feb 12 | A · derivative | 1,100 | $0.00 | $0 | 3,230 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 10 | Feb 12 | A · derivative | 4,100 | $284.50 | $1,166,450 | 4,100 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 10 | Feb 12 | A · derivative | 1,360 | $0.00 | $0 | 2,757 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 10 | Feb 12 | A · derivative | 1,900 | $284.50 | $540,550 | 1,900 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 10 | Feb 12 | A · derivative | 620 | $0.00 | $0 | 1,534 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 10 | Feb 12 | A · derivative | 2,400 | $284.50 | $682,800 | 2,400 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 10 | Feb 12 | A · derivative | 810 | $0.00 | $0 | 2,420 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 10 | Feb 12 | A · derivative | 1,300 | $284.50 | $369,850 | 1,300 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 10 | Feb 12 | A · derivative | 440 | $0.00 | $0 | 2,664 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 10 | Feb 12 | A · derivative | 7,100 | $284.50 | $2,019,950 | 7,100 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 10 | Feb 12 | A · derivative | 2,350 | $0.00 | $0 | 5,824 | No | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Feb 10 | Feb 12 | A · derivative | 2,200 | $284.50 | $625,900 | 2,200 | No | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Feb 10 | Feb 12 | A · derivative | 730 | $0.00 | $0 | 4,354 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Feb 10 | Feb 12 | A · derivative | 2,700 | $284.50 | $768,150 | 2,700 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Feb 10 | Feb 12 | A · derivative | 880 | $0.00 | $0 | 2,480 | No | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 10 | Feb 12 | S | 91 | $276.79 | Sale −$25,188 | 2,696.33 | Yes | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 10 | Feb 12 | A · derivative | 1,900 | $284.50 | $540,550 | 1,900 | Yes | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 10 | Feb 12 | A · derivative | 620 | $0.00 | $0 | 2,937 | Yes | Form 4 |
| Schechter Adam HPresident & CEO | Feb 10 | Feb 12 | A · derivative | 31,700 | $284.50 | $9,018,650 | 31,700 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 10 | Feb 12 | A · derivative | 10,440 | $0.00 | $0 | 25,870 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 9 | Feb 10 | F | 85 | $274.01 | $23,291 | 3,906 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 9 | Feb 10 | F | 23 | $274.01 | $6,302 | 3,883 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 9 | Feb 10 | F | 80 | $274.01 | $21,921 | 5,574.5 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 9 | Feb 10 | F | 112 | $274.01 | $30,689 | 1,213 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Feb 9 | Feb 10 | F | 61 | $274.01 | $16,715 | 3,288.46 | No | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 9 | Feb 10 | S | 88 | $275.53 | Sale −$24,247 | 2,869.33 | Yes | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 9 | Feb 10 | F | 82 | $274.01 | $22,469 | 2,787.33 | Yes | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Feb 9 | Feb 10 | F | 61 | $274.01 | $16,715 | 5,382.57 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Feb 9 | Feb 10 | F | 93 | $274.01 | $25,483 | 2,849.49 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 9 | Feb 10 | F | 166 | $274.01 | $45,486 | 5,979.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 9 | Feb 10 | F | 53 | $274.01 | $14,523 | 5,926.14 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 9 | Feb 10 | F | 46 | $274.01 | $12,604 | 2,028.22 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 9 | Feb 10 | F | 1,352 | $274.01 | $370,462 | 92,616 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 9 | Feb 10 | F | 51 | $274.01 | $13,975 | 3,944.25 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 9 | Feb 10 | F | 148 | $274.01 | $40,553 | 31,109.92 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 9 | Feb 10 | F | 32 | $274.01 | $8,768 | 31,077.92 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 7 | Feb 10 | M | 222 | not reported | not reported | 3,924 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 7 | Feb 10 | M | 67 | not reported | not reported | 3,991 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 7 | Feb 10 | M · derivative | 222 | $0.00 | $0 | 2,197 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 7 | Feb 10 | M · derivative | 67 | $0.00 | $0 | 2,130 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 7 | Feb 10 | M | 222 | not reported | not reported | 5,654.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 7 | Feb 10 | M · derivative | 222 | $0.00 | $0 | 914 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 7 | Feb 10 | M | 367 | not reported | not reported | 1,325 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 7 | Feb 10 | M · derivative | 367 | $0.00 | $0 | 1,397 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Feb 7 | Feb 10 | M | 178 | not reported | not reported | 3,349.46 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Feb 7 | Feb 10 | M · derivative | 178 | $0.00 | $0 | 1,600 | No | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 7 | Feb 10 | M | 263 | not reported | not reported | 2,957.33 | Yes | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 7 | Feb 10 | M · derivative | 263 | $0.00 | $0 | 2,317 | Yes | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Feb 7 | Feb 10 | M | 178 | not reported | not reported | 5,443.57 | No | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Feb 7 | Feb 10 | M · derivative | 178 | $0.00 | $0 | 3,624 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Feb 7 | Feb 10 | M | 353 | not reported | not reported | 2,942.49 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Feb 7 | Feb 10 | M · derivative | 353 | $0.00 | $0 | 1,517 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 7 | Feb 10 | M | 517 | not reported | not reported | 5,981.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 7 | Feb 10 | M | 164 | not reported | not reported | 6,145.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 7 | Feb 10 | M · derivative | 517 | $0.00 | $0 | 3,328 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 7 | Feb 10 | M · derivative | 164 | $0.00 | $0 | 3,164 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 7 | Feb 10 | M | 134 | not reported | not reported | 2,074.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 7 | Feb 10 | M · derivative | 134 | $0.00 | $0 | 2,224 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 7 | Feb 10 | M | 3,249 | not reported | not reported | 93,968 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 7 | Feb 10 | M · derivative | 3,249 | $0.00 | $0 | 15,430 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 7 | Feb 10 | M | 149 | not reported | not reported | 3,995.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 7 | Feb 10 | M · derivative | 149 | $0.00 | $0 | 1,610 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 7 | Feb 10 | M | 517 | not reported | not reported | 31,146.92 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 7 | Feb 10 | M | 111 | not reported | not reported | 31,257.92 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 7 | Feb 10 | M · derivative | 517 | $0.00 | $0 | 3,001 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 7 | Feb 10 | M · derivative | 111 | $0.00 | $0 | 2,890 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 6 | Feb 10 | M | 180 | not reported | not reported | 3,774 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 6 | Feb 10 | F | 72 | $277.20 | $19,958 | 3,702 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 6 | Feb 10 | M · derivative | 180 | $0.00 | $0 | 2,419 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 6 | Feb 10 | M | 223 | not reported | not reported | 5,524.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 6 | Feb 10 | F | 92 | $277.20 | $25,502 | 5,432.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 6 | Feb 10 | M · derivative | 223 | $0.00 | $0 | 1,136 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 6 | Feb 10 | M | 327 | not reported | not reported | 1,077 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 6 | Feb 10 | F | 119 | $277.20 | $32,987 | 958 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 6 | Feb 10 | M · derivative | 327 | $0.00 | $0 | 1,764 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Feb 6 | Feb 10 | M | 180 | not reported | not reported | 3,232.46 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Feb 6 | Feb 10 | F | 61 | $277.20 | $16,909 | 3,171.46 | No | Form 4 |
| Kyle Kathryn WEVP, Chief Legal Officer | Feb 6 | Feb 10 | M · derivative | 180 | $0.00 | $0 | 1,778 | No | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 6 | Feb 10 | M | 267 | not reported | not reported | 2,785.33 | Yes | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 6 | Feb 10 | F | 91 | $277.20 | $25,225 | 2,694.33 | Yes | Form 4 |
| Meltzer Jonathan CEVP, Operations | Feb 6 | Feb 10 | M · derivative | 267 | $0.00 | $0 | 2,580 | Yes | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Feb 6 | Feb 10 | M | 180 | not reported | not reported | 5,326.57 | No | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Feb 6 | Feb 10 | F | 61 | $277.20 | $16,909 | 5,265.57 | No | Form 4 |
| Vaughn Bryan TEVP, Diagnostics | Feb 6 | Feb 10 | M · derivative | 180 | $0.00 | $0 | 3,802 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Feb 6 | Feb 10 | M | 387 | not reported | not reported | 2,690.49 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Feb 6 | Feb 10 | F | 101 | $277.20 | $27,997 | 2,589.49 | No | Form 4 |
| van der Vaart Sandra DEVP, Corporate Affairs | Feb 6 | Feb 10 | M · derivative | 387 | $0.00 | $0 | 1,870 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 6 | Feb 10 | M | 743 | not reported | not reported | 5,703.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 6 | Feb 10 | F | 239 | $277.20 | $66,251 | 5,464.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 6 | Feb 10 | M · derivative | 743 | $0.00 | $0 | 3,845 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 6 | Feb 10 | M | 133 | not reported | not reported | 1,985.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 6 | Feb 10 | F | 45 | $277.20 | $12,474 | 1,940.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 6 | Feb 10 | M · derivative | 133 | $0.00 | $0 | 2,358 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 6 | Feb 10 | M | 4,460 | not reported | not reported | 92,034 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 6 | Feb 10 | F | 1,315 | $277.20 | $364,518 | 90,719 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 6 | Feb 10 | M · derivative | 4,460 | $0.00 | $0 | 18,679 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 6 | Feb 10 | M | 180 | not reported | not reported | 3,907.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 6 | Feb 10 | F | 61 | $277.20 | $16,909 | 3,846.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 6 | Feb 10 | M · derivative | 180 | $0.00 | $0 | 1,759 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 6 | Feb 10 | M | 670 | not reported | not reported | 30,838.92 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 6 | Feb 10 | F | 209 | $277.20 | $57,935 | 30,629.92 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 6 | Feb 10 | M · derivative | 670 | $0.00 | $0 | 3,518 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 6 | Feb 10 | M | 893 | not reported | not reported | 1,456.24 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 6 | Feb 10 | F | 254 | $277.20 | $70,409 | 1,202.24 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 6 | Feb 10 | M · derivative | 893 | $0.00 | $0 | 3,474 | No | Form 4 |
| Bulto Carulla Victor | Dec 1, 2025 | Dec 3, 2025 | A · derivative | 136 | $0.00 | $0 | 136 | No | Form 4 |
| Schechter Adam HPresident & CEO | Nov 11, 2025 | Nov 13, 2025 | S | 5,745 | $262.75 | Sale −$1,509,499 | 87,574 | Yes | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Nov 3, 2025 | Nov 4, 2025 | F | 107 | $257.84 | $27,589 | 3,727.25 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Nov 3, 2025 | Nov 4, 2025 | F | 179 | $257.84 | $46,153 | 3,594 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Nov 1, 2025 | Nov 4, 2025 | M | 370 | not reported | not reported | 3,834.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Nov 1, 2025 | Nov 4, 2025 | M · derivative | 370 | $0.00 | $0 | 1,939 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Nov 1, 2025 | Nov 4, 2025 | M | 370 | not reported | not reported | 3,773 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Nov 1, 2025 | Nov 4, 2025 | M · derivative | 370 | $0.00 | $0 | 2,599 | No | Form 4 |
| Parham Richelle P | Oct 31, 2025 | Nov 4, 2025 | S | 7,009 | $254.28 | Sale −$1,782,249 | 2,469 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Aug 13, 2025 | Aug 15, 2025 | M | 3,903 | $131.43 | $512,971 | 6,176.67 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Aug 13, 2025 | Aug 15, 2025 | S | 3,903 | $271.42 | Sale −$1,059,352 | 2,273.67 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Aug 13, 2025 | Aug 15, 2025 | M · derivative | 3,903 | $131.43 | $512,971 | not reported | No | Form 4 |
| Schechter Adam HPresident & CEO | Aug 11, 2025 | Aug 13, 2025 | S | 5,643 | $266.78 | Sale −$1,505,440 | 93,319 | Yes | Form 4 |
| Gilliland Dwight Gary | Jul 30, 2025 | Aug 1, 2025 | S | 2,000 | $264.95 | Sale −$529,900 | 6,656 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Jul 29, 2025 | Jul 31, 2025 | S | 102 | $261.01 | Sale −$26,623 | 1,952.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Jul 29, 2025 | Jul 31, 2025 | S | 100 | $261.04 | Sale −$26,104 | 1,852.22 | No | Form 4 |
| Anderson Kerrii B | Jul 24, 2025 | Jul 28, 2025 | S | 3,500 | $280.00 | Sale −$980,000 | 8,666 | Yes | Form 4 |
| Anderson Kerrii B | Jul 24, 2025 | Jul 28, 2025 | S | 3,500 | $280.00 | Sale −$980,000 | 8,666 | Yes | Form 4 |
| Anderson Kerrii B | Jul 1, 2025 | Jul 2, 2025 | S | 500 | $265.00 | Sale −$132,500 | 12,166 | Yes | Form 4 |
| Anderson Kerrii B | Jun 11, 2025 | Jun 12, 2025 | S | 500 | $260.00 | Sale −$130,000 | 12,666 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Jun 3, 2025 | Jun 5, 2025 | S | 2,000 | $247.00 | Sale −$494,000 | 30,066.66 | No | Form 4 |
| Schechter Adam HPresident & CEO | May 12, 2025 | May 13, 2025 | S | 6,105 | $248.73 | Sale −$1,518,497 | 98,962 | Yes | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | May 1, 2025 | May 5, 2025 | S | 829 | $242.27 | Sale −$200,842 | 2,054.22 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | May 1, 2025 | May 5, 2025 | S | 1,900 | $238.36 | Sale −$452,884 | 2,243.54 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Apr 1, 2025 | Apr 3, 2025 | M | 4,083 | not reported | not reported | 4,813 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Apr 1, 2025 | Apr 3, 2025 | F | 1,546 | $232.65 | $359,677 | 3,267 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Apr 1, 2025 | Apr 3, 2025 | M | 204 | not reported | not reported | 3,471 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Apr 1, 2025 | Apr 3, 2025 | F | 68 | $232.65 | $15,820 | 3,403 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Apr 1, 2025 | Apr 3, 2025 | M · derivative | 4,083 | $0.00 | $0 | 3,173 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Apr 1, 2025 | Apr 3, 2025 | M · derivative | 204 | $0.00 | $0 | 2,969 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Mar 28, 2025 | Mar 31, 2025 | S | 2,635 | $231.67 | Sale −$610,450 | 4,960.14 | Yes | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Mar 28, 2025 | Mar 31, 2025 | S | 758 | $231.67 | Sale −$175,606 | 5,301.5 | Yes | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Mar 27, 2025 | Mar 31, 2025 | A | 688 | $0.00 | $0 | 3,662.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Mar 27, 2025 | Mar 31, 2025 | F | 198 | $231.67 | $45,871 | 3,464.25 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Mar 27, 2025 | Mar 31, 2025 | A | 1,249 | $0.00 | $0 | 3,242.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Mar 27, 2025 | Mar 31, 2025 | F | 359 | $231.67 | $83,170 | 2,883.22 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Mar 27, 2025 | Mar 31, 2025 | A | 4,840 | $0.00 | $0 | 34,175.66 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Mar 27, 2025 | Mar 31, 2025 | F | 2,109 | $231.67 | $488,592 | 32,066.66 | No | Form 4 |
| Berberian LanceEVP, Special Advisor, Strategy | Mar 27, 2025 | Mar 31, 2025 | A | 3,325 | $0.00 | $0 | 20,005 | No | Form 4 |
| Berberian LanceEVP, Special Advisor, Strategy | Mar 27, 2025 | Mar 31, 2025 | F | 1,353 | $231.67 | $313,450 | 18,652 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Mar 27, 2025 | Mar 31, 2025 | A | 8,305 | $0.00 | $0 | 41,550 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Mar 27, 2025 | Mar 31, 2025 | F | 3,630 | $231.67 | $840,962 | 37,920 | No | Form 4 |
| Schechter Adam HPresident & CEO | Mar 27, 2025 | Mar 31, 2025 | A | 30,469 | $0.00 | $0 | 118,651 | No | Form 4 |
| Schechter Adam HPresident & CEO | Mar 27, 2025 | Mar 31, 2025 | F | 13,584 | $231.67 | $3,147,005 | 105,067 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Mar 27, 2025 | Mar 31, 2025 | A | 3,325 | $0.00 | $0 | 5,495.54 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Mar 27, 2025 | Mar 31, 2025 | F | 1,352 | $231.67 | $313,218 | 4,143.54 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Mar 27, 2025 | Mar 31, 2025 | A | 4,840 | $0.00 | $0 | 9,800.14 | Yes | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Mar 27, 2025 | Mar 31, 2025 | F | 2,205 | $231.67 | $510,832 | 7,595.14 | Yes | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Mar 27, 2025 | Mar 31, 2025 | A | 2,077 | $0.00 | $0 | 6,621.5 | Yes | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Mar 27, 2025 | Mar 31, 2025 | F | 562 | $231.67 | $130,199 | 6,059.5 | Yes | Form 4 |
| Anderson Kerrii B | Mar 5, 2025 | Mar 7, 2025 | S | 500 | $255.63 | Sale −$127,815 | 13,166 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 28, 2025 | Mar 4, 2025 | M | 3,903 | $131.43 | $512,971 | 10,299.14 | Yes | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 28, 2025 | Mar 4, 2025 | S | 5,339 | $249.23 | Sale −$1,330,639 | 4,960.14 | Yes | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 28, 2025 | Mar 4, 2025 | M · derivative | 3,903 | $131.43 | $512,971 | not reported | Yes | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 25, 2025 | Feb 27, 2025 | S | 1,314 | $251.30 | Sale −$330,208 | 2,170.54 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 24, 2025 | Feb 26, 2025 | S | 226 | $250.40 | Sale −$56,590 | 4,544.5 | Yes | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 18, 2025 | Feb 20, 2025 | M | 1,413 | $163.63 | $231,209 | 3,406.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 18, 2025 | Feb 20, 2025 | S | 1,413 | $246.10 | Sale −$347,739 | 1,993.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 18, 2025 | Feb 20, 2025 | M · derivative | 1,413 | $163.63 | $231,209 | not reported | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Aug 1, 2022 | Feb 20, 2025 | G | 351 | $0.00 | $0 | 1,993.22 | No | Form 4 |
| Kliphouse Kirsten Marie | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 897 | $0.00 | $0 | 897 | No | Form 4 |
| Anderson Kerrii B | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 897 | $0.00 | $0 | 897 | No | Form 4 |
| Davis Jeffrey A. | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 897 | $0.00 | $0 | 897 | No | Form 4 |
| Gilliland Dwight Gary | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 897 | $0.00 | $0 | 897 | No | Form 4 |
| Kong Garheng | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 897 | $0.00 | $0 | 897 | No | Form 4 |
| Neupert Peter M | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 897 | $0.00 | $0 | 897 | No | Form 4 |
| Parham Richelle P | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 897 | $0.00 | $0 | 897 | No | Form 4 |
| Rothman Paul | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 897 | $0.00 | $0 | 897 | No | Form 4 |
| Wengel Kathryn E | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 897 | $0.00 | $0 | 897 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 7,800 | $245.14 | $1,912,092 | 7,800 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 2,580 | $0.00 | $0 | 4,367 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 11, 2025 | Feb 13, 2025 | M | 134 | not reported | not reported | 3,016.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 11, 2025 | Feb 13, 2025 | F | 42 | $245.14 | $10,296 | 2,974.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 2,100 | $245.14 | $514,794 | 2,100 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 690 | $0.00 | $0 | 2,443 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 11, 2025 | Feb 13, 2025 | M · derivative | 134 | $0.00 | $0 | 2,309 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 3,200 | $245.14 | $784,448 | 3,200 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 1,070 | $0.00 | $0 | 2,091 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 11, 2025 | Feb 13, 2025 | M | 473 | not reported | not reported | 6,530.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 11, 2025 | Feb 13, 2025 | F | 134 | $245.14 | $32,849 | 6,396.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 7,300 | $245.14 | $1,789,522 | 7,300 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 2,420 | $0.00 | $0 | 5,061 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 11, 2025 | Feb 13, 2025 | M · derivative | 473 | $0.00 | $0 | 4,588 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 11, 2025 | Feb 13, 2025 | M | 323 | not reported | not reported | 3,570.54 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 11, 2025 | Feb 13, 2025 | F | 86 | $245.14 | $21,082 | 3,484.54 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 3,400 | $245.14 | $833,476 | 3,400 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 1,130 | $0.00 | $0 | 2,580 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 11, 2025 | Feb 13, 2025 | M · derivative | 323 | $0.00 | $0 | 2,257 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 11, 2025 | Feb 13, 2025 | M | 473 | not reported | not reported | 29,471.66 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 11, 2025 | Feb 13, 2025 | F | 136 | $245.14 | $33,339 | 29,335.66 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 6,700 | $245.14 | $1,642,438 | 6,700 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 2,220 | $0.00 | $0 | 4,661 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 11, 2025 | Feb 13, 2025 | M · derivative | 473 | $0.00 | $0 | 4,188 | No | Form 4 |
| Berberian LanceEVP, Special Advisor, Strategy | Feb 11, 2025 | Feb 13, 2025 | M | 323 | not reported | not reported | 16,766 | No | Form 4 |
| Berberian LanceEVP, Special Advisor, Strategy | Feb 11, 2025 | Feb 13, 2025 | F | 86 | $245.14 | $21,082 | 16,680 | No | Form 4 |
| Berberian LanceEVP, Special Advisor, Strategy | Feb 11, 2025 | Feb 13, 2025 | M · derivative | 323 | $0.00 | $0 | 1,067 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Feb 11, 2025 | Feb 13, 2025 | M | 807 | not reported | not reported | 33,458 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Feb 11, 2025 | Feb 13, 2025 | F | 213 | $245.14 | $52,215 | 33,245 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Feb 11, 2025 | Feb 13, 2025 | M · derivative | 807 | $0.00 | $0 | 2,819 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 11, 2025 | Feb 13, 2025 | S | 6,121 | $244.62 | Sale −$1,497,319 | 86,445 | Yes | Form 4 |
| Schechter Adam HPresident & CEO | Feb 11, 2025 | Feb 13, 2025 | M | 2,963 | not reported | not reported | 89,408 | Yes | Form 4 |
| Schechter Adam HPresident & CEO | Feb 11, 2025 | Feb 13, 2025 | F | 1,226 | $245.14 | $300,542 | 88,182 | Yes | Form 4 |
| Schechter Adam HPresident & CEO | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 33,100 | $245.14 | $8,114,134 | 33,100 | Yes | Form 4 |
| Schechter Adam HPresident & CEO | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 10,970 | $0.00 | $0 | 26,102 | Yes | Form 4 |
| Schechter Adam HPresident & CEO | Feb 11, 2025 | Feb 13, 2025 | M · derivative | 2,963 | $0.00 | $0 | 23,139 | Yes | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 3,700 | $245.14 | $907,018 | 3,700 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 1,210 | $0.00 | $0 | 7,256 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 11, 2025 | Feb 13, 2025 | M | 201 | not reported | not reported | 4,825.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 11, 2025 | Feb 13, 2025 | F | 55 | $245.14 | $13,483 | 4,770.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 2,100 | $245.14 | $514,794 | 2,100 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 690 | $0.00 | $0 | 1,560 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 11, 2025 | Feb 13, 2025 | M · derivative | 201 | $0.00 | $0 | 1,359 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11, 2025 | Feb 13, 2025 | M | 123 | not reported | not reported | 2,385.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11, 2025 | Feb 13, 2025 | F | 41 | $245.14 | $10,051 | 2,344.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 1,500 | $245.14 | $367,710 | 1,500 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 480 | $0.00 | $0 | 1,004 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11, 2025 | Feb 13, 2025 | A · derivative | 1,610 | $0.00 | $0 | 2,614 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 11, 2025 | Feb 13, 2025 | M · derivative | 123 | $0.00 | $0 | 2,491 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 7, 2025 | Feb 10, 2025 | M | 369 | not reported | not reported | 869 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 7, 2025 | Feb 10, 2025 | F | 119 | $246.27 | $29,306 | 750 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 369 | $0.00 | $0 | 1,021 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 7, 2025 | Feb 10, 2025 | M | 354 | not reported | not reported | 3,341.54 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 7, 2025 | Feb 10, 2025 | F | 94 | $246.27 | $23,149 | 3,247.54 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 354 | $0.00 | $0 | 1,450 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 7, 2025 | Feb 10, 2025 | M | 3,250 | not reported | not reported | 93,911 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 7, 2025 | Feb 10, 2025 | F | 1,345 | $246.27 | $331,233 | 92,566 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 3,250 | $0.00 | $0 | 15,132 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 7, 2025 | Feb 10, 2025 | M | 134 | not reported | not reported | 2,308.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 7, 2025 | Feb 10, 2025 | F | 46 | $246.27 | $11,328 | 2,262.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 134 | $0.00 | $0 | 524 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 7, 2025 | Feb 10, 2025 | M | 517 | not reported | not reported | 6,086.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 7, 2025 | Feb 10, 2025 | F | 146 | $246.27 | $35,955 | 5,940.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 7, 2025 | Feb 10, 2025 | M | 164 | not reported | not reported | 6,104.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 7, 2025 | Feb 10, 2025 | F | 47 | $246.27 | $11,575 | 6,057.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 517 | $0.00 | $0 | 2,805 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 164 | $0.00 | $0 | 2,641 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 7, 2025 | Feb 10, 2025 | M | 224 | not reported | not reported | 4,692.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 7, 2025 | Feb 10, 2025 | F | 68 | $246.27 | $16,746 | 4,624.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 224 | $0.00 | $0 | 870 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 7, 2025 | Feb 10, 2025 | M | 149 | not reported | not reported | 2,933.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 7, 2025 | Feb 10, 2025 | F | 51 | $246.27 | $12,560 | 2,882.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 149 | $0.00 | $0 | 1,753 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 7, 2025 | Feb 10, 2025 | M | 224 | not reported | not reported | 770 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 7, 2025 | Feb 10, 2025 | F | 85 | $246.27 | $20,933 | 685 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 7, 2025 | Feb 10, 2025 | M | 67 | not reported | not reported | 752 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 7, 2025 | Feb 10, 2025 | F | 22 | $246.27 | $5,418 | 730 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 224 | $0.00 | $0 | 6,113 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 67 | $0.00 | $0 | 6,046 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 7, 2025 | Feb 10, 2025 | M | 517 | not reported | not reported | 29,068.66 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 7, 2025 | Feb 10, 2025 | F | 149 | $246.27 | $36,694 | 28,919.66 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 7, 2025 | Feb 10, 2025 | M | 112 | not reported | not reported | 29,031.66 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 7, 2025 | Feb 10, 2025 | F | 33 | $246.27 | $8,127 | 28,998.66 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 517 | $0.00 | $0 | 2,553 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 112 | $0.00 | $0 | 2,441 | No | Form 4 |
| Berberian LanceEVP, Special Advisor, Strategy | Feb 7, 2025 | Feb 10, 2025 | M | 354 | not reported | not reported | 16,537 | No | Form 4 |
| Berberian LanceEVP, Special Advisor, Strategy | Feb 7, 2025 | Feb 10, 2025 | F | 94 | $246.27 | $23,149 | 16,443 | No | Form 4 |
| Berberian LanceEVP, Special Advisor, Strategy | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 354 | $0.00 | $0 | 1,390 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Feb 7, 2025 | Feb 10, 2025 | M | 885 | not reported | not reported | 32,885 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Feb 7, 2025 | Feb 10, 2025 | F | 234 | $246.27 | $57,627 | 32,651 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Feb 7, 2025 | Feb 10, 2025 | M · derivative | 885 | $0.00 | $0 | 3,626 | No | Form 4 |
| Gilliland Dwight Gary | Feb 6, 2025 | Feb 10, 2025 | M | 944 | not reported | not reported | 8,656 | No | Form 4 |
| Gilliland Dwight Gary | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 944 | $0.00 | $0 | not reported | No | Form 4 |
| Rothman Paul | Feb 6, 2025 | Feb 10, 2025 | M | 944 | not reported | not reported | 1,674 | No | Form 4 |
| Rothman Paul | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 944 | $0.00 | $0 | not reported | No | Form 4 |
| Anderson Kerrii B | Feb 6, 2025 | Feb 10, 2025 | M | 944 | not reported | not reported | 13,666 | No | Form 4 |
| Anderson Kerrii B | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 944 | $0.00 | $0 | not reported | No | Form 4 |
| Kliphouse Kirsten Marie | Feb 6, 2025 | Feb 10, 2025 | M | 944 | not reported | not reported | 2,263 | No | Form 4 |
| Kliphouse Kirsten Marie | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 944 | $0.00 | $0 | not reported | No | Form 4 |
| Davis Jeffrey A. | Feb 6, 2025 | Feb 10, 2025 | M | 944 | not reported | not reported | 4,563 | No | Form 4 |
| Davis Jeffrey A. | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 944 | $0.00 | $0 | not reported | No | Form 4 |
| Kong Garheng | Feb 6, 2025 | Feb 10, 2025 | M | 944 | not reported | not reported | 12,842 | No | Form 4 |
| Kong Garheng | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 944 | $0.00 | $0 | not reported | No | Form 4 |
| Neupert Peter M | Feb 6, 2025 | Feb 10, 2025 | M | 944 | not reported | not reported | 12,887 | No | Form 4 |
| Neupert Peter M | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 944 | $0.00 | $0 | not reported | No | Form 4 |
| Parham Richelle P | Feb 6, 2025 | Feb 10, 2025 | M | 944 | not reported | not reported | 9,478 | No | Form 4 |
| Parham Richelle P | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 944 | $0.00 | $0 | not reported | No | Form 4 |
| Wengel Kathryn E | Feb 6, 2025 | Feb 10, 2025 | M | 944 | not reported | not reported | 3,236 | No | Form 4 |
| Wengel Kathryn E | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 944 | $0.00 | $0 | not reported | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 6, 2025 | Feb 10, 2025 | M | 893 | not reported | not reported | 893 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 6, 2025 | Feb 10, 2025 | F | 336 | $247.74 | $83,241 | 557 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 893 | $0.00 | $0 | 1,787 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 6, 2025 | Feb 10, 2025 | M | 326 | not reported | not reported | 618 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 6, 2025 | Feb 10, 2025 | F | 118 | $247.74 | $29,233 | 500 | No | Form 4 |
| Graham Anita ZEVP, CHRO | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 326 | $0.00 | $0 | 1,390 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 6, 2025 | Feb 10, 2025 | M | 386 | not reported | not reported | 3,089.54 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 6, 2025 | Feb 10, 2025 | F | 102 | $247.74 | $25,269 | 2,987.54 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 386 | $0.00 | $0 | 1,804 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 6, 2025 | Feb 10, 2025 | M | 4,460 | not reported | not reported | 91,901 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 6, 2025 | Feb 10, 2025 | F | 1,240 | $247.74 | $307,198 | 90,661 | No | Form 4 |
| Schechter Adam HPresident & CEO | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 4,460 | $0.00 | $0 | 18,382 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 6, 2025 | Feb 10, 2025 | M | 133 | not reported | not reported | 2,220.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 6, 2025 | Feb 10, 2025 | F | 46 | $247.74 | $11,396 | 2,174.22 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 133 | $0.00 | $0 | 658 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 6, 2025 | Feb 10, 2025 | M | 743 | not reported | not reported | 5,779.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 6, 2025 | Feb 10, 2025 | F | 210 | $247.74 | $52,025 | 5,569.14 | No | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 743 | $0.00 | $0 | 3,322 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 6, 2025 | Feb 10, 2025 | M | 223 | not reported | not reported | 4,541.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 6, 2025 | Feb 10, 2025 | F | 73 | $247.74 | $18,085 | 4,468.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 223 | $0.00 | $0 | 1,094 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 6, 2025 | Feb 10, 2025 | M | 180 | not reported | not reported | 2,846.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 6, 2025 | Feb 10, 2025 | F | 62 | $247.74 | $15,360 | 2,784.25 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 180 | $0.00 | $0 | 1,902 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 6, 2025 | Feb 10, 2025 | M | 180 | not reported | not reported | 616 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 6, 2025 | Feb 10, 2025 | F | 70 | $247.74 | $17,342 | 546 | No | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 180 | $0.00 | $0 | 6,337 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 6, 2025 | Feb 10, 2025 | M | 670 | not reported | not reported | 28,763.66 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 6, 2025 | Feb 10, 2025 | F | 212 | $247.74 | $52,521 | 28,551.66 | No | Form 4 |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 670 | $0.00 | $0 | 3,070 | No | Form 4 |
| Berberian LanceEVP, Special Advisor, Strategy | Feb 6, 2025 | Feb 10, 2025 | M | 356 | not reported | not reported | 16,277 | No | Form 4 |
| Berberian LanceEVP, Special Advisor, Strategy | Feb 6, 2025 | Feb 10, 2025 | F | 94 | $247.74 | $23,288 | 16,183 | No | Form 4 |
| Berberian LanceEVP, Special Advisor, Strategy | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 356 | $0.00 | $0 | 1,744 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Feb 6, 2025 | Feb 10, 2025 | M | 966 | not reported | not reported | 32,255 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Feb 6, 2025 | Feb 10, 2025 | F | 255 | $247.74 | $63,174 | 32,000 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Feb 6, 2025 | Feb 10, 2025 | M · derivative | 966 | $0.00 | $0 | 4,511 | No | Form 4 |
| Anderson Kerrii B | Jan 7, 2025 | Jan 8, 2025 | S | 1,000 | $235.00 | Sale −$235,000 | 12,722 | Yes | Form 4 |
| Gilliland Dwight Gary | Dec 2, 2024 | Dec 4, 2024 | S | 1,000 | $241.00 | Sale −$241,000 | 7,712 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Dec 2, 2024 | Dec 4, 2024 | M | 8,923 | $209.25 | $1,867,138 | 40,212 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Dec 2, 2024 | Dec 4, 2024 | M | 2,788 | $221.67 | $618,016 | 43,000 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Dec 2, 2024 | Dec 4, 2024 | S | 11,711 | $240.43 | Sale −$2,815,676 | 31,289 | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Dec 2, 2024 | Dec 4, 2024 | M · derivative | 8,923 | $209.25 | $1,867,138 | not reported | No | Form 4 |
| Eisenberg Glenn AExecutive Vice President | Dec 2, 2024 | Dec 4, 2024 | M · derivative | 2,788 | $221.67 | $618,016 | 5,577 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Dec 2, 2024 | Dec 4, 2024 | A · derivative | 8,100 | $240.63 | $1,949,103 | 8,100 | No | Form 4 |
| Wang Julia AijunChief Financial Officer, EVP | Dec 2, 2024 | Dec 4, 2024 | A · derivative | 2,680 | $0.00 | $0 | 2,680 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Nov 22, 2024 | Nov 26, 2024 | M | 4,015 | $168.52 | $676,608 | 7,990 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Nov 22, 2024 | Nov 26, 2024 | S | 3,671.5 | $238.91 | Sale −$877,158 | 4,318.5 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Nov 22, 2024 | Nov 26, 2024 | M · derivative | 4,015 | $168.52 | $676,608 | not reported | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Nov 21, 2024 | Nov 25, 2024 | S | 1,000 | $239.42 | Sale −$239,420 | 2,669.85 | No | Form 4 |
| Schechter Adam HPresident & CEO | Nov 11, 2024 | Nov 13, 2024 | S | 6,189 | $243.47 | Sale −$1,506,836 | 87,441 | Yes | Form 4 |
| Bailey Megan D.EVP, Pres, Central Labs & Intl | Nov 1, 2024 | Nov 5, 2024 | A · derivative | 1,110 | $0.00 | $0 | 6,517 | No | Form 4 |
| Oyegunwa AkinboladeEVP, CIO & CTO | Nov 1, 2024 | Nov 5, 2024 | A · derivative | 1,110 | $0.00 | $0 | 2,082 | No | Form 4 |
| Anderson Kerrii B | Oct 24, 2024 | Oct 25, 2024 | S | 1,000 | $230.00 | Sale −$230,000 | 13,722 | Yes | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Aug 19, 2024 | Aug 21, 2024 | S | 2,000 | $227.05 | Sale −$454,100 | 3,669.85 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Aug 15, 2024 | Aug 19, 2024 | S | 2,979 | $222.65 | Sale −$663,274 | 43,310 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Aug 15, 2024 | Aug 19, 2024 | S | 2,950 | $223.62 | Sale −$659,679 | 40,360 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Aug 15, 2024 | Aug 19, 2024 | S | 9,071 | $224.55 | Sale −$2,036,893 | 31,289 | No | Form 4 |
| Anderson Kerrii B | Aug 8, 2024 | Aug 9, 2024 | S | 586 | $225.00 | Sale −$131,850 | 14,722 | Yes | Form 4 |
| Anderson Kerrii B | Aug 7, 2024 | Aug 9, 2024 | S | 414 | $225.00 | Sale −$93,150 | 15,308 | Yes | Form 4 |
| Berberian LanceEVP, CIO & CTO | Aug 5, 2024 | Aug 7, 2024 | S | 2,245 | $229.79 | Sale −$515,879 | 25,769 | No | Form 4 |
| Berberian LanceEVP, CIO & CTO | Aug 5, 2024 | Aug 7, 2024 | S | 9,848 | $228.95 | Sale −$2,254,700 | 15,921 | No | Form 4 |
| Rothman Paul | Jun 6, 2024 | Jun 10, 2024 | M | 717 | not reported | not reported | 717 | No | Form 4 |
| Rothman Paul | Jun 6, 2024 | Jun 10, 2024 | M · derivative | 717 | $0.00 | $0 | 944 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | May 14, 2024 | May 16, 2024 | S | 1,800 | $210.83 | Sale −$379,494 | 5,836.98 | No | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | May 14, 2024 | May 16, 2024 | S | 200 | $210.84 | Sale −$42,168 | 5,636.98 | No | Form 4 |
| Anderson Kerrii B | May 2, 2024 | May 2, 2024 | S | 250 | $200.10 | Sale −$50,025 | 15,722 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Apr 30, 2024 | May 2, 2024 | M | 10,229 | not reported | not reported | 50,785 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Apr 30, 2024 | May 2, 2024 | F | 4,496 | $201.37 | $905,360 | 46,289 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Apr 30, 2024 | May 2, 2024 | M · derivative | 10,229 | not reported | not reported | not reported | No | Form 4 |
| Anderson Kerrii B | Apr 30, 2024 | May 2, 2024 | S | 250 | $204.14 | Sale −$51,035 | 15,972 | No | Form 4 |
| Wilkinson Peter JSVP, Chief Accounting Officer | Apr 29, 2024 | May 1, 2024 | S | 2,439 | $204.33 | Sale −$498,361 | 2,087.22 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Apr 15, 2024 | Apr 17, 2024 | M | 10,229 | not reported | not reported | 45,052 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Apr 15, 2024 | Apr 17, 2024 | F | 4,496 | $203.32 | $914,127 | 40,556 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Apr 15, 2024 | Apr 17, 2024 | M · derivative | 10,229 | $0.00 | $0 | 5,477 | No | Form 4 |
| Bailey Megan D.EVP, Chief Strategy Officer | Apr 1, 2024 | Apr 3, 2024 | M | 205 | not reported | not reported | 505 | No | Form 4 |
| Bailey Megan D.EVP, Chief Strategy Officer | Apr 1, 2024 | Apr 3, 2024 | F | 69 | $216.35 | $14,928 | 436 | No | Form 4 |
| Bailey Megan D.EVP, Chief Strategy Officer | Apr 1, 2024 | Apr 3, 2024 | M · derivative | 205 | $0.00 | $0 | 5,407 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Apr 1, 2024 | Apr 3, 2024 | S | 3,500 | $217.29 | Sale −$760,515 | 3,975 | Yes | Form 4 |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Apr 1, 2024 | Apr 3, 2024 | S | 6,477 | $217.29 | Sale −$1,407,387 | 5,036.14 | Yes | Form 4 |
| van der Vaart Sandra DEVP, Chief Legal Officer | Mar 28, 2024 | Mar 29, 2024 | S | 3,553 | $216.74 | Sale −$770,077 | 7,636.98 | Yes | Form 4 |
| Berberian LanceEVP, CIO & CTO | Mar 27, 2024 | Mar 29, 2024 | M | 7,697 | not reported | not reported | 31,313 | No | Form 4 |
| Berberian LanceEVP, CIO & CTO | Mar 27, 2024 | Mar 29, 2024 | F | 3,299 | $216.57 | $714,464 | 28,014 | No | Form 4 |
| Berberian LanceEVP, CIO & CTO | Mar 27, 2024 | Mar 29, 2024 | M · derivative | 7,697 | not reported | not reported | 2,100 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Mar 27, 2024 | Mar 29, 2024 | M | 20,033 | not reported | not reported | 43,628 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Mar 27, 2024 | Mar 29, 2024 | F | 8,805 | $216.57 | $1,906,899 | 34,823 | No | Form 4 |
| Eisenberg Glenn AChief Financial Officer, EVP | Mar 27, 2024 | Mar 29, 2024 | M · derivative | 20,033 | not reported | not reported | 15,706 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Mar 27, 2024 | Mar 29, 2024 | M | 5,778 | not reported | not reported | 9,637 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Mar 27, 2024 | Mar 29, 2024 | F | 2,162 | $216.57 | $468,224 | 7,475 | No | Form 4 |
| Summy Amy B.EVP, Chief Marketing Officer | Mar 27, 2024 | Mar 29, 2024 | M · derivative | 5,778 | not reported | not reported | 1,317 | No | Form 4 |